The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
December 26th 2024
From groundbreaking therapies to ethical dilemmas, HCPLive’s top podcasts of 2024 delivered expert insights and human stories across medicine.
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Diabetic Kidney Disease: New Consensus Document
October 22nd 2014Prompted by almost-epidemic rates of diabetes in the United States and globally, the American Diabetes Association recently convened a consensus panel to examine diabetic kidney disease, one of the most frequent complications associated with diabetes.
Target-Specific Oral Anticoagulants Are Associated with Reduced Risk of Bleeding
Analysis of a dozen phase III trials indicates that patients with atrial fibrillation face significantly less risk of major, fatal, and intracranial bleeding if they take target-specific oral anticoagulants rather than vitamin K antagonists.
Tales of the Anion Gap, Part III: Case Examples
October 21st 2014Calculation and interpretation of the anion gap is extremely useful in the evaluation and treatment of the patient with metabolic acidosis. In this installment, we look at case examples involving patients with multiple sclerosis and urosepsis; COPD, diabetes, and renal failure; and type 1 diabetes.
Perfusion Devices Raise Transplant Hopes
Could portable perfusion devices be a game-changer for organ transplants? The machines keep organs "alive" for days at warm temperatures. That prolongs cell life, slowing the race against the damage that can set in within hours when donor organs are kept on ice in coolers. Manufacturer TransMedics, based in Andover, MA, makes devices for the lung, heart, and liver Researchers and clinicians express growing excitement-along with some skepticism-at the prospect that these medical devices could dramatically increase the viability of donor organs.
New Guidelines to Prevent Atrial Fibrillation
The American Association for Thoracic Surgery (AATS) has released new guidelines designed to prevent the occurrence of atrial fibrillation (AF) in thousands of patients who undergo lung surgery in the United States each year.
Getting Kids Off the Couch Just One Part of Obesity Battle
The days of sitting in front of the television with an Atari controller or driving Mario around on his cart are largely over but even the more interactive video games do not do enough to keep this generation of children healthy.
Utility of the Ankle-brachial Index in Clinical Practice: A Q&A with Harry Agis
October 10th 2014Harry Agis, MD, is a vascular surgeon and a partner in the New Jersey Vein Institute, Morristown, NJ. He speaks with Internal Medicine World Report Editor-in-Chief, Simon Douglas Murray, MD about the utility of the ankle-brachial index (ABI) in screening for peripheral artery disease and atherosclerosis and then will touch briefly on a few other subjects that might be relevant to internists with regards to vascular surgery.
Obese Children Have Heart Damage
Heart trouble can start early for obese children, a German research team found. Writing in the Journal of the American College of Cardiology, Norman Manger, MD, and colleagues compared blood pressure, low-density lipoprotein cholesterol, and glucose metabolism in 61 obese children with that of 40 children with healthy weights. The obese group had an average BMI of about 31 while the control group's average BMI was about 20.
Non-Cardiac Surgery in Adult Congenital Heart Disease: Not Child's Play
October 8th 2014Study results show that the majority of adult patients with congenital heart disease and their clinicians ignore American College of Cardiology and American Heart Association recommendations that any non-cardiac surgery for these patients should be performed in regionalized centers of expertise.
Will the FDA Tighten the Use of Testosterone Replacement Therapy?
A recommendation by two FDA advisory panels to narrow the official approval for testosterone replacement therapy has won generally favorable reviews from medical organizations, although questions remain about its ultimate impact.
Evolocumab Phase 3 Trials Show Efficacy in Lowering Cholesterol
For patients with heterozygous familial hypercholesterolemia, statin therapy is often not enough to reduce LDL cholesterol. In two articles in The Lancet, researchers report on promising results of two international Phase 3 trials of evolocumab. The drug is a monoclonal antibody to proprotein convertase sudbtilism/kexin type 9 (PCSK9).
In-hospital Pharmacologic Prophylaxis not Linked to Decrease in Venous Thromboembolism Prophylaxis
October 2nd 2014A study published in the Journal of the American Medical Association found hospitals' administration of pharmacologic venous thromboembolism (VTE) prophylaxis was not associated with lower rates of VTE.
Hemoglobin A1c Levels Act as an Independent Gauge for Coronary Artery Disease
October 2nd 2014For individuals without diabetes, hemoglobin A1c (HbA1c) levels not only predicted the prevalence of coronary artery disease (CAD), but also anticipated its severity, according to research published in Mayo Clinic Proceedings.
Patient Participation in the Electronic Health Record Process
As more practices and hospitals enter the digital age with Electronic Health Records (EHR) and other health information technology tools, a recent article points out that all those efforts are only half the battle.